Skip to content

PainChek® is a medical device: ALWAYS FOLLOW THE DIRECTIONS FOR USE. Landmark US FDA De Novo Grant received for PainChek Adult

Learn More

Lil Bianchi

Non-Executive Director and Non-Executive Chair of the Board

BSc(Econ), MSc Computer Science, GAICD

Lil brings a proven track record of guiding medical technology companies as they navigate growth inflection points and accelerate global market adoption including the US and Europe. With deep expertise spanning business transformation, AI and SaaS technologies, governance and capital markets, she has helped lead companies through expansion, commercialisation and international growth.

Her experience across global corporates, tech start-ups and IPO environments positions her to guide companies in scaling innovative medical technologies into major healthcare markets. Combining board, CEO and senior executive leadership experience with a strong background in strategy, risk and digital disruption, Lil has a demonstrated ability to help companies convert breakthrough technology into commercial traction and long-term shareholder value.

Lil is Chair of medtech company 4DMedical (ASX:4DX), a global leader in respiratory imaging that has grown from IPO in 2020 to a $2b+ market capitalisation and entry to the ASX200 in 2026.
Non-Executive Director of Qscan Radiology Group. Founded in 2006, Qscan has grown to more than 80 clinics focused on diagnostic medical imaging and interventional procedures across five Australian states. Non-Executive Director of Water company Murrumbidgee Irrigation.

More Team Members

David Allsopp

General Manager & Head of Business Development, North America

John Murray

Non-Executive Director

Natalie Climo

Company Secretary

Prof Jeff Hughes

Chief Scientific Officer